Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway

Glioblastomas (GBMs) are a lethal class of brain cancer, with a median survival <15 months in spite of therapeutic advances. The poor prognosis of GBM is largely attributed to acquired chemotherapy resistance, and new strategies are urgently needed to target resistant glioma cells. Here we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yujiang, He, Xijun, Chen, Huihui, Duan, Hongyu, Shao, Bo, Yang, Fan, Li, Huiyong, Yang, Pengxiang, Zeng, Yu, Zheng, Jinrong, Li, Yongsheng, Hu, Jiachang, Lin, Liguo, Teng, Lingfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131327/
https://www.ncbi.nlm.nih.gov/pubmed/30061180
http://dx.doi.org/10.1042/BSR20181051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131327/
https://www.ncbi.nlm.nih.gov/pubmed/30061180
http://dx.doi.org/10.1042/BSR20181051

Ejemplares similares